rosiglitazone has been researched along with Necrosis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Duan, Y; Han, J; Liu, L; Yang, S; Yang, X; Zhang, S | 1 |
| Cao, Y; He, W; Huang, J; Li, X; Wang, J | 1 |
| Li, S; Peng, S; Ruan, W; Xiao, F; Xu, J | 1 |
| Adeyi, OA; Echeverri, J; Farrokhi, K; Ganesh, S; Hamar, M; Kaths, JM; Kollmann, D; Linares, I; Selzner, M; Selzner, N; Urbanellis, P; Yip, P | 1 |
| Cabay, RJ; Castellanos, KJ; Fantuzzi, G; Grady, EF; Pini, M; Rhodes, DH | 1 |
| de la Lastra, CA; Martín, AR; Toma, W; Villegas, I | 1 |
| Bonyhay, L; Ratziu, V; Tahiri, M | 1 |
| Chen, JJ; Cheung, WM; Lin, H; Lin, TN; Liou, JY; Shyue, SK; Wu, JS; Wu, KK | 1 |
| Chen, XG; Fu, J; Li, H; Li, J; Liu, Y; Meng, Y | 1 |
| Brandt, U; Brüne, B; Dröse, S; Soller, M; von Knethen, A | 1 |
| Bernhardt, C; Bruckert, E; Charlotte, F; Giral, P; Grimaldi, A; Hartemann-Heurtier, A; Jacqueminet, S; Lacorte, JM; Podevin, P; Poynard, T; Ratziu, V; Serfaty, L | 1 |
1 review(s) available for rosiglitazone and Necrosis
| Article | Year |
|---|---|
[Nonalcoholic steatohepatitis].
Topics: Chronic Disease; Fatty Liver; Humans; Inflammation; Liver; Necrosis; PPAR gamma; Rosiglitazone; Thiazolidinediones; Vasodilator Agents; Vitamin E Deficiency | 2005 |
1 trial(s) available for rosiglitazone and Necrosis
| Article | Year |
|---|---|
Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial.
Topics: Adiponectin; Adult; Aged; Alanine Transaminase; Fatty Liver; Female; Fibrosis; gamma-Glutamyltransferase; Hepatitis; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Middle Aged; Necrosis; Placebos; Rosiglitazone; Thiazolidinediones | 2008 |
9 other study(ies) available for rosiglitazone and Necrosis
| Article | Year |
|---|---|
A novel therapy for hepatic cholestasis treatment-the combination of rosiglitazone and fenofibrate.
Topics: Animals; Cholestasis; Fenofibrate; Liver; Mice; Mice, Inbred C57BL; Necrosis; Rosiglitazone; Ursodeoxycholic Acid | 2023 |
Rosiglitazone Protects against Acetaminophen-Induced Acute Liver Injury by Inhibiting Multiple Endoplasmic Reticulum Stress Pathways.
Topics: Acetaminophen; Animals; Chemical and Drug Induced Liver Injury; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Liver; Male; Mice; Necrosis; Oxidative Stress; Rosiglitazone | 2022 |
PPAR-
Topics: Animals; Apoptosis; Cardiotonic Agents; Cecum; Cytokines; DNA; Heart; Inflammation; Ligation; Male; Myocardium; Myocytes, Cardiac; Necrosis; NF-kappa B; NF-KappaB Inhibitor alpha; PPAR gamma; Protein Binding; Punctures; Rats, Sprague-Dawley; Rosiglitazone; Sepsis; Survival Analysis; Thiazolidinediones | 2017 |
PPAR-gamma activation is associated with reduced liver ischemia-reperfusion injury and altered tissue-resident macrophages polarization in a mouse model.
Topics: Alanine Transaminase; Anilides; Animals; Apoptosis; Aspartate Aminotransferases; Cell Polarity; Cytokines; Disease Models, Animal; Kupffer Cells; Lectins, C-Type; Liver; Male; Mannose Receptor; Mannose-Binding Lectins; Mice; Mice, Inbred C57BL; Necrosis; Nitric Oxide; PPAR gamma; Receptors, Cell Surface; Reperfusion Injury; Rosiglitazone; Thiazolidinediones | 2018 |
Rosiglitazone improves survival and hastens recovery from pancreatic inflammation in obese mice.
Topics: Adiponectin; Adipose Tissue; Adiposity; Animal Feed; Animals; Diet, Fat-Restricted; Diet, High-Fat; Dietary Fats; Erythropoiesis; Hypoglycemic Agents; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Necrosis; Pancreas; Rosiglitazone; Thiazolidinediones; Time Factors | 2012 |
Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against gastric ischemia-reperfusion damage in rats: role of oxygen free radicals generation.
Topics: Animals; Cyclooxygenase 1; Cyclooxygenase 2; Gastric Mucosa; Glutathione Peroxidase; Immunohistochemistry; Male; Membrane Proteins; Necrosis; Neutrophils; Oxidative Stress; Peroxidase; PPAR gamma; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Reactive Oxygen Species; Reperfusion Injury; Rosiglitazone; Stomach; Superoxide Dismutase; Thiazolidinediones; Tumor Necrosis Factor-alpha; Up-Regulation; Xanthine Oxidase | 2004 |
15d-prostaglandin J2 protects brain from ischemia-reperfusion injury.
Topics: Adenoviridae; Animals; Apoptosis; Caspase 3; Caspases; Cells, Cultured; Cyclooxygenase 1; Gene Transfer Techniques; Genetic Therapy; Heme Oxygenase-1; Infarction, Middle Cerebral Artery; Male; Necrosis; Neurons; Neuroprotective Agents; PPAR gamma; Prostaglandin D2; Rats; Rats, Long-Evans; Reperfusion Injury; Rosiglitazone; Thiazolidinediones; Vasodilator Agents | 2006 |
Growth inhibition and differentiation induced by peroxisome proliferator activated receptor gamma ligand rosiglitazone in human melanoma cell line A375.
Topics: Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Separation; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Models, Biological; Necrosis; PPAR gamma; Proto-Oncogene Proteins c-bcl-2; Rosiglitazone; Thiazolidinediones; Time Factors | 2006 |
Mechanism of thiazolidinedione-dependent cell death in Jurkat T cells.
Topics: Adenosine Triphosphate; Apoptosis; Cell Death; Cell Line, Tumor; Cell Survival; Chromans; Humans; Jurkat Cells; Mitochondria; Necrosis; PPAR gamma; Reactive Oxygen Species; Rosiglitazone; T-Lymphocytes; Thiazolidinediones; Troglitazone | 2007 |